Merck & Co., Inc.
NYSE-MRK
Basic
Market Cap
$327.32B
EV
$356.55B
Shares Out
2,533.03M
Revenue
$61.4B
Employees
71,000
Margins
Gross
74.85%
EBITDA
16.87%
Operating
10.85%
Pre-Tax
6.37%
Net
3.76%
FCF
15.21%
Returns (5Yr Avg)
ROA
10.22%
ROTA
59.59%
ROE
28.13%
ROCE
18.61%
ROIC
14.97%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$141.31
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,093M
Net Debt
$29.18B
Debt/Equity
0.96
EBIT/Interest
5.52
Growth (CAGR)
Rev 3Yr
13.63%
Rev 5Yr
7.35%
Rev 10Yr
3.48%
Dil EPS 3Yr
-31.33%
Dil EPS 5Yr
-22.3%
Dil EPS 10Yr
-5.11%
Rev Fwd 2Yr
6.77%
EBITDA Fwd 2Yr
81.1%
EPS Fwd 2Yr
155.75%
EPS LT Growth Est
38.19%
Dividends
Yield
—
Payout
325.43%
DPS
$2.96
DPS Growth 3Yr
6.08%
DPS Growth 5Yr
8.26%
DPS Growth 10Yr
5.52%
DPS Growth Fwd 2Yr
4.43%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)